Part of the Luxembourg Institute of Health, IBBL is a recognised partner for any R&D activities in France. According to the French research tax credit, all innovative businesses collaborating with IBBL may be eligible for a tax relief on their R&D expenses, regardless of their size.
The Crédit d’impôt recherche (CIR – research tax credit) is a fiscal policy that drives research and innovation on the French territory. It aims to foster a dynamic and favorable environment for all R&D companies operating in the country by means of an attractive tax incentive. Concretely, businesses and associations of all sectors of activity, including the pharmaceutical industries, can claim a tax relief of up to 50% on their R&D expenditures. The tool is key in making France an attractive location for innovation.
Dedicated to supporting biomedical research for the benefit of patients, IBBL offers a full range of biobanking services, including the collection, processing, analysis and storage of biological samples and associated data. In addition, the Biobank carries out research to optimise biospecimen processing and certify biospecimen quality. Located just a few kilometers from the French border, IBBL is an ideal partner for any research projects eligible for the French tax credit.
For further information about the CIR, please visit this website.